fluconazole and ati 5923

fluconazole has been researched along with ati 5923 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bavisotto, LM; Canafax, DM; Combs, DL; Ellis, DJ; Irwin, I; Milner, PG	1

Trials

1 trial(s) available for fluconazole and ati 5923

Article	Year
Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy participants. Journal of clinical pharmacology, 2011, Volume: 51, Issue:4 Topics: Administration, Oral; Adult; Aryl Hydrocarbon Hydroxylases; Benzoates; Coumarins; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Humans; Male; NAD(P)H Dehydrogenase (Quinone); Warfarin	2011

Article

Year

Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy participants.

Journal of clinical pharmacology, 2011, Volume: 51, Issue:4

Topics: Administration, Oral; Adult; Aryl Hydrocarbon Hydroxylases; Benzoates; Coumarins; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Humans; Male; NAD(P)H Dehydrogenase (Quinone); Warfarin

2011